Comparative safety and efficacy of cefdinir vs. amoxicillin/clavulanate for treatment of suppurative acute otitis media in children

Pediatric Infectious Disease Journal

Volumn 19, Issue 12 SUPPL., 2000, Pages

  Block, S L ^a   McCarty, J M ^a   Hedrick, J A ^a   Nemeth, M A ^a  

^a NONE   (United States)

Author keywords

Acute otitis media; Amoxicillin clavulanate; Cefdinir; Children

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFDINIR; CEPHALOSPORIN DERIVATIVE;

ACUTE DISEASE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ACUTE DISEASE; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; MALE; OTITIS MEDIA, SUPPURATIVE; TREATMENT OUTCOME;

EID: 0034543537     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200012001-00005     Document Type: Article

References (35)

1. Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain
2. Management of acute otitis media in the 1990s: The decade of resistant pneumococcus
3. Cefprozil treatment of persistent and recurrent acute otitis media
4. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics
5. Management of acute otitis media caused by resistant pneumococci in infants
6. Measuring the comparative efficacy of antibacterial agents for acute otitis media: The 'Pollyanna phenomenon.'
7. In vitro activity evaluations of cefdinir (FK 482, CI-983, PD 134393)
8. In vitro activity of cefdinir (FK 482) and ten other antibiotics against Gram-positive and Gram-negative bacteria isolated from adult and pediatric patients
9. The in vitro activity of cefdinir (FK482), a new oral cephalosporin
10. Clinical studies of cefdinir in pediatric infections
11. In vitro activity of cefditoren against clinical isolates of S. pneumoniae, H. influenzae, and M. catarrhalis
12. Activity of cefditoren compared with other agents against quinolone and macrolide susceptible and resistant pneumococci
13. Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses
14. Comparative safety and efficacy of cefdinir and cephalexin in the treatment of acute skin and skin structure infections
15. Comparative safety and efficacy of cefdinir and penicillin V-K in the treatment of streptococcal pharyngitis/tonsillitis
16. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children
17. Acute otitis media: Management and surveillance in an era of pneumococcal resistance - A report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group
18. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media
19. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: Risk factors susceptibility patterns and antimicrobial management
20. Five-day cefdinir therapy for acute otitis media: Microbiologic and clinical efficacy
21. Five-day twice daily cefdinir course vs. ten day cefprozil course for treatment of acute otitis media
22. MICs of H. influenzae and M. catarrhalis from acute otitis media
23. Cefdinir (FK-482), an orally administered cephalosporin, in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines
24. MICs of penicillin-resistant S. pneumoniae from acute otitis media
25. Rational selection of antimicrobials for pediatric upper respiratory infections
26. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
27. Host factors and early therapeutic response in otitis media
28. Duration of therapy for acute otitis media
29. Acceptance of antibiotic mixtures by infants and children
30. Variation in acceptance of common oral antibiotic suspensions
31. The effect of prescribed daily dose frequency on patient medication compliance
32. Selection of pediatric antibiotic suspensions: Taste and cost factors
33. Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients